NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Pharma POOL Anne NOBLES Dr.Thomas VERHOEVEN Lilly Announces Personnel Changes Eli Lilly, Indianapolis, has promoted Anne Nobles to VP of corporate affairs from Strattera product team leader. Ms. Nobles has replaced Deborah Steelman, who resigned for personal reasons. In her new role, she leads governmental affairs, public policy, external corporate commu nications, executive communications, internal communications, community relations, corpo rate branding, and corporate contributions. Ms. Nobles joined Lilly in 1990 as manag er of public affairs and later moved to medical regulatory affairs. She was promoted to direc tor of public policy planning and development in 1994 and, in 1998, was promoted to lead the businesstobusiness organization in Lilly’s U.S. affiliate (LillyUSA). In 1999, she was named Strattera team leader, where she helped lead the successful approval and launch of the product in the United States for the treatment of ADHD in children, adolescents, and adults. She received bachelor’s and master’s degrees in anthropology from Harvard University in 1978 and 1979, respectively. She received a law degree in 1984 from Georgetown University. In addition, Thomas Verhoeven, Ph.D., has joined Lilly Research Laboratories in the newly created position of VP of process and product development Dr. Verhoeven has joined Lilly from Merck where he most recently served as senior VP of global operations and strategic research plan ning for Merck Research Laboratories. At Lilly, Dr. Verhoeven oversees the technical manage ment and commercial development aspects of worldwide operations of process and product development for both biological and pharma ceutical drug candidates. Dr. Verhoeven received a bachelor of sci ence degree in chemistry from the University of Michigan and a doctorate in organic chem istry from the University of Wisconsin. Biopharmaceutical POOL Dr. Michael WILLIAMS Cephalon Hires VP,Worldwide Discovery Research C e p h a l o n , We s t Chester, Pa., has appointed Michael Williams, Ph.D., D.Sc., as VP of worldwide discovery research. Dr. Williams has more than 25 years of experi ence in pharmaceutical drug discovery. In his new role, Dr. Williams has responsibility for all activities related to the discovery of novel ther apeutics for the treatment of central nervous system and oncologic diseases. In his most recent position, Dr. Williams served as VP of drug discovery for Molecumetics. Previously, Dr. Williams was with Abbott Laboratories from 1989 to 2000 where he served as divi sional VP of neuroscience and urological dis eases. Dr. Williams earned his Ph.D. in neuro chemistry and a doctor of science degree in pharmacology from the University of London. Emerging POOL Michael W.BONNEY Cubist Pharmaceuticals Announces Execution of Succession Plan Michael W. Bonney has succeeded Scott M. Rocklage, Ph.D., as Cubist Pharmaceuti cals’s CEO. Dr. Rock lage, formerly chair man and CEO, remains the company’s chairman. Cubist, Lex ington, Mass., is focused on becoming a glob al leader in the research, development, and commercialization of novel pharmaceuticals to combat serious and lifethreatening infections. Dr. Jerry KARABELAS Halsey Pharmaceuticals Appoints Chairman Halsey Pharmaceuticals has appointed Jerry Karabelas, Ph.D., chairman. Halsey Pharmaceuticals is an emerging pharmaceuti cal company specializing in innovative drug development, primarily for pain management. In his new capacity, Dr. Karabelas, who has been a director of the company since Decem ber 2002, oversees the overall strategy and direction of the company. Dr. Karabelas was head of healthcare and CEO of worldwide pharmaceuticals for Novartis AG from 1998 until July 2000. He holds a Ph.D. in pharmacokinetics from the Massachusetts College of Pharmacy and serves as a director of SkyePharma, Human Genome Sciences, Nitromed, Anadys, Vanda Pharmaceuticals, and Renovo. Dr. Karabelas replaces Michael K. Reicher, who is retiring and is assisting in the transi tion. The company has begun to search for a new CEO. Discovery POOL Dr.Thomas D. INGOLIA CEO Named for Myriad Proteomics Thomas D. Ingolia, Ph.D., has joined Myr iad Proteomics, Salt Lake City, as president 60 A ug u s t 20 03 PharmaVOICE TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY and CEO. Myriad Pro teomics, a privately held spinoff of Myriad Genet ics, employs high throughput protein inter action research to discover diseaserelated biomark ers, validated targets, and lead compounds. After 13 years at Eli Lilly, working in research, process development, marketing, and technology management, Dr. Ingolia held lead ership roles as senior VP and chief operating officer of Ontogeny (now known as Curis) and president and chief operating officer of Microbia. Dr. Ingolia received a MBA from Indiana University, a B.S. in chemistry from the Uni versity of Illinois, and a Ph.D. in biochemistry from the University of California, Berkeley. His postdoctoral training was at the Universi ty of California, San Francisco and at the Uni versity of Wisconsin. Genomics POOL Gregory T. LUCIER Invitrogen Appoints President and CEO Invitrogen has named Gregory T. Lucier to the positions of pres ident and CEO. Invitrogen, Carls bad, Calif., develops, manufactures, and markets research tools in kit form for biotechnology researchers and companies worldwide. Previously, Mr. Lucier was president and CEO of General Electric’s Medical Systems Information Technologies busi ness unit. Mr. Lucier holds a MBA degree from Harvard University and a bachelor’s degree in industrial engineer ing from Pennsylvania State University. Dr. Anne M.PILARO Former FDA Executive Joins Gene Logic Anne M. Pilaro, Ph.D., has joined Gene Logic’s TherImmune Research Corp. subsidiary as senior director for reg ulatory affairs. Gene Logic, Gaithersburg, Md., provides a broad range of genomics information and bioinformatics solutions and integrated contract research services. Dr. Pilaro is responsible for advising clients on regula tory policies of and sub missions to the FDA. Dr. Pilaro spent 10 years at the FDA, most recently as the expert tox icologist for cellular and gene therapies at the Office of Therapeutics Research and Review in the Center for Biologics Evaluation and Research at the FDA. Dr. Pilaro has a Ph.D. in toxicology from Rutgers University and a B.A. in biochem istry from Russell Sage College. CRO POOL John KROBATH Cliff MORRIS Darren SMITH PRA International Promotes Key Employees PRA International, a global clinical research organization located in McLean, Va., has announced several promotions that sup port the company’s con tinued expansion. Darren Smith has been promoted to senior pro posal and contract coordi nator. Mr. Smith, who is located at the Char lottesville, Va., office, is responsible for propos al/RFP and change order generation and manage ment, as well as the man agement and supervision of the Charlottesville office proposal team. John Krobath has been promoted to manager of business operations for the North American Monitoring Group (NAMG). In his new role as a manager of business oper ations, Mr. Krobath’s experience in finance brings a new perspective and an added dimension to the operations side of the NAMG business. Mr. Krobath is locat ed at PRA’s headquarters. Cliff Morris has been promoted to senior manager, proposal development. In his new role as a senior manager, all North America proposal managers report to him. At the same time, he is leading the cen tral proposal group. TALENT pool Dr. Donald J. PALMISANO Donald J. Palmisano, M.D., J.D., has been appointed president of the Chicagobased Amer ican Medical Association. Dr. Palmisano, the first AMA president licensed to practice law, has dedicated his yearlong presidency to preserving patient access to care by advancing medical lia bility reform as the AMA’s highest legislative priority. Dr. Palmisano played a key role in the passage of the landmark Louisiana Medical Malpractice Act of 1975, helping to implement reforms that capped medical liability damages. He believes that the battle for reform is a difficult, but impor tant one. “We cannot expect change — we cannot effect change — if we do not work for change,” Dr. Palmisano says. “And in this work — we can never give up. If we desert this battle, we will lose the most experienced of the practitioners among us and cripple the next generation of physicians.” Dr. Palmisano was first elected to the AMA Board of Trustees in 1996 and has been a member of the exec utive committee since 1999 and served as AMA secretarytreasurer in 2001. He also served as president of the Louisiana State Medical Society from 1984 to 1985 and was elected to the society’s Hall of Fame in 2000. In addi tion, Dr. Palmisano is a clinical professor of surgery and clinical professor of medical jurisprudence at Tulane University School of Medicine where he received his med ical degree in 1963. He is a fellow of the American College of Surgeons. He obtained a juris doctorate from Loyola University School of Law in New Orleans in 1982. AMANAMES 158TH PRESIDENT The AMA’s new president plans to lead the charge for medical liability reform. 61 PharmaVOICE A ug u s t 20 03 62 Au gu s t 2 00 3 PharmaVOICE TALENT pool Service POOL Eileen CATTIE Furia Rubel Communications Names Executive VP Eileen Cattie has joined Furia Rubel Com munications as executive VP. Ms. Cattie’s responsibilities include management of all nonlegal clients and expansion of the compa ny’s current business interests into the con sumer arena. Furia Rubel, Perkasie, Pa., is an integrated strategic communications firm spe cializing in public relations, marketing, and business development. Most recently, Ms. Cattie was the director of corporate communications for QVC. Dennis DEROSIA ReSearch Pharmaceutical Services Announces Strategic Development Team Member ReSearch Pharmaceutical Services (RPS), a pharmaceutical resource organization provid ing customized solutions to assist compa nies with the management and execution of their clinical drug programs, has added Dennis DeRosia as senior director of strategic development. Mr. DeRosia oversees the Plymouth Meeting, Pa. based company’s West Coast business development activities. He has 27 years experience in the med ical field and clinical research industry and has worked to advance clinical research as a profession through leadership roles in the Association of Clinical Research Pro fessionals where he serves on the board of trustees as the immediate past chairman. Dr. Susan FINN Former President of the American Dietetic Association Joins FleishmanHillard Susan Finn, Ph.D., a registered dietician and former president of the American Dietetic Association, has joined St. Louis based Fleishman Hillard International Communications as a senior consultant. Before joining FleishmanHillard, a publicrelations firm and part of The Omnicom Group, she was at Ross Prod ucts for more than 20 years as director of the nutrition and communications department. Pam LORD Atkins +Associates Announces Hire Atkins + Associates, a public and investor rela tions consulting firm spe cializing in biobusiness communications, has pro moted Pam Lord to account supervisor. Ms. Lord joined San Diego based Atkins + Associates in September 2001 as senior account executive. She supervises account work and develops strate gic media and investor relations campaigns. Joseph R. WAGER NewVP of Research and Business Development at Prescription Solutions Prescription Solutions, a national pharmacy and medicalmanagement company based in San Diego, has named Joseph R. Wager VP of research and business development. The new position merges business development and outcomes research, as well as clinical research functions into a single dedicated depart ment. In his new role, he enhances the company’s efforts in prospective and retrospective research, tar geted surveys, predictive modeling, targeted dis ease interventions, and safety intelligence. Mr. Wager had been with Medicus. He has a M.S. in neurobiology from the University of Illinois and a MBA from the University of Chicago. Contract Sales POOL Eva D. MITCHELL Caswood Group NamesVP,New Business Development Eva D. Mitchell has been appointed VP of new business development for The Caswood Teresa BITETTI Rex HARMON Brian MCEVILLY The Medical Marketing Asso ciation, San Francisco, has named its three Marketers of the Year in the areas of device, diagnostics, and pharmaceutical/biotechnolo gy/biologics. The awards are pre sented annually in recognition of individuals and teams who make exceptional leadership contributions to outstand ing, resultsoriented marketing programs. Teresa Bitetti, senior director of Abilify mar keting at BristolMyers Squibb, has been named the Pharma/Biotech/Biologics Marketer of the Year. She was chosen for successfully positioning and championing a unique branding campaign for Abilify (aripiprazole), an atypical antipsychot ic for the treatment of schizophrenia. The 2003 Medical Device Marketer of the Year is Rex Harmon, VP of global marketing and PR Manager of Swissray International. He was chosen for spearheading highly successful mar keting campaigns to gain market share and increase brand recognition for Swissray’s direct digital Radiography technology. The Medical Diagnostics Marketer of the Year is Brian McEvilly, marketing manager of Quidel. He is recognized for his leadership in developing and implementing a creative strategy to penetrate a new marketing chan nel for the QuickVue Influenza rapid diag nostic test. MEDICAL MARKETING ASSOCIATION NAMES MARKETERS OFTHEYEAR Teresa Bitetti, Rex Harmon, and Brian McEvilly are recognized by The Medical Marketing Association for their contributions to marketing. 64 Au gu s t 2 00 3 PharmaVOICE TALENT pool rology advisors for new neurology education programs. Dr. Cummings is the Augustus S. Rose Professor of Neurology in the departments of psychiatry and biobehavioral sciences at the UCLA School of Medicine, and director of the UCLA Alzheimer’s Disease Center in Los Angeles. Dr. Salloway is director of neurology and the Memory Disorders Program at Butler Hospital and associate professor of clinical neurosciences and psychiatry at Brown Medi cal School. Consulting POOL Ajay MUNSHI Bogart Delafield Ferrier NamesVP Ajay Munshi has been promoted to the position of VP at Bogart Delafield Ferrier, Par sippany, N.J., a management consulting firm that focuses exclusively on strategy consulting in the pharmaceutical, biotechnology, and medicaldevice industries. Mr. Munshi joined BDF in 1999 and in his new position he con tinues to lead client engagements and new business development initiatives. Mr. Munshi holds a B.S. from Johns Hop kins and a MBA from Columbia University. Dr. Matthew W. REYNOLDS MetaWorks Names Head of Risk Management and Safety Services Program MetaWorks, a Med ford, Mass.based health care consulting company focused on clinicaldrug development and com mercialization within the pharmaceutical, biotech nology, and healthcare industries, has appointed Matthew W. Reynolds, Ph.D., as senior direc tor of its riskmanagement and safetyservices program. Dr. Reynolds, a pharmacoepidemiologist with research background in drug safety and metaanalysis, is shaping the expansion of the program and overseeing its management going forward. Dr. Reynolds also serves as principal investigator on sponsored research projects. Before joining MetaWorks, Dr. Reynolds was associate director of epidemiology at AstraZeneca. With an undergraduate degree in mathe matics from Loyola College, Dr. Reynolds earned his graduate and doctoral degrees in epidemiology and preventive medicine from the University of Maryland. Technology POOL Dr. Rami BENJOSEPH Health Process Management NamesVP,Operations Health Process Man agement (HPM), a data management and analyt ics firm under the inChord Communica tions’ umbrella of com panies, has named Rami BenJoseph, Ph.D., as VP of operations. Dr. BenJoseph oversees operations at the Doylestown, Pa.based company and leads project teams involving medical, statistical, and health outcomes work. Dr. BenJoseph joins HPM from Pharma cia, where he most recently served as senior director of global pricing, reimbursement, and health outcomes. Dr. BenJoseph holds a doc torate in health administration from the Uni versity of Florida’s Medical School and a bach elor’s degree in pharmacy from Hebrew University of Israel’s Medical School. Philip LEE PHT Appoints President and CEO PHT, Charlestown, Mass., a provider of mobile electronic patient diary solutions for clinical trials, has appointed Philip Lee as president and CEO. “We’re very pleased that Mr. Lee has joined the company, contributing his significant experi ence as a corporate leader in the clinicaltrials software space to further PHT’s growth,” says Steve Raymond, PHT’s founder and chief sci entific officer. “His proven leadership skills and substantial clinical trials experience will serve PHT well in the years to come.” Most recently, Mr. Lee served as the presi dent of eXcelon. Before that, Mr. Lee served as the president and CEO of Clinsoft. Mr. Lee Group, Fairport, N.Y., a fullservice contractsales organization. Ms. Mitchell formerly was VP of sales and princi pal consultant for Analyti ka, a data and informatics company serving the phar maceutical industry. Before Analytika, she held various seniorman agement positions at GlaxoSmithKline, including regional VP of sales, director of salesforce automation, and senior manager of sales reporting. Medical Education POOL Dr. Jeffrey CUMMINGS Peter PAYERLI Dr. Stephen SALLOWAY CME Adds Senior Sales Director and Neurology Advisors CME, an independent provider of continuing medical education located in Irvine, Calif., has added Peter Payerli as senior sales director. In his new position, Mr. Payerli focuses his 20 years of publishing and advertising experience on the areas of psychia try, neurology, geriatrics, and primary care. He is responsible for growing current pharmaceu tical client relationships. In 1993, he joined the American Medical Association (AMA), where he was named pub lisher of the Archives Journals division. He served on the executive committee of the publish ing management board for the AMA, guiding overall strategy for the publishing division. He also was a member of the board for the Association of Medical Publications and was elected as its VP in 2001. Mr. Payerli is a graduate of Columbia Col lege in Chicago. In addition, Jeffrey Cummings, M.D., and Stephen Salloway, M.D., M.S., have joined the company to serve as neu 65 PharmaVOICE A ug u s t 200 3 TALENT pool also has served in senior level positions at Ora cle, BBN, and Interleaf. “I’m very excited about joining PHT at this critical time when the market for EPD solu tions is expanding rapidly. I believe PHT is well positioned to capitalize on this growing market,” Mr. Lee says. “I look forward to lever aging PHT’s considerable assets to take the company to its next stage of growth.” Dr. Paul MARTINETTI AXIS Healthcare Communications Names VP of Digital AXIS AXIS Healthcare Communications, Yard ley, Pa., has appointed Paul Martinetti, M.D., as VP of Digital AXIS. In this newly created capaci ty, Dr. Martinetti is devel oping the framework for AXIS’ ebusiness offer ings and work with thirdparty technology partners to develop and manage a wide range of technology solutions in support of the healthcare communications programs offered by the AXIS group of companies. In particular, Dr. Martinetti is focusing on educational programs, including CME pro grams that are accessible via modern digital channels, including but not limited to the Web, CDROM, and DVD. Dr. Martinetti joined AXIS from Dudnyk Healthcare Group. He earned his medical degree from UMDNJNew Jersey Medical School and completed an internship in family medicine at CrozerChester Medical Center. Gary RICH Mindspan Names Business Development Director Mindspan, an interac tive brand promotion and physician learning orga nization located in Mah wah, N.J., has appointed Gary Rich as director of business development. Mr. Rich’s primary responsibility is to launch an interactive directtophysician e detailing initiative for the company’s phar maceutical clients. This initiative includes Internetbased promotional sessions, adviso ry sessions (for consultants), and market research. Mr. Rich recently held the position of chief operating officer at Dot Com Advisors. Before this position, he served as executive VP and client service director at Sudler & Hennessey. Media POOL Brett COGAN Gary FALCETANO Victoria HELLER Chad HOLLOWAY Steve SVEC Clinicians Group Announces Promotions,Additions to Staff Clinicians Group, Bloomfield, N.J., the medical publishing arm of Jobson LLC, a healthcare communications company, has made staffing changes in its publishing entities. In the Physician Assistant/Nurse Practi tioner Publishing Group, Gary Falcetano, PA C, has been promoted to associate publisher for the Clinician Reviews and Clinician News publications. Victoria Heller, FNP, has joined the PA/NP group as account manager. In the Neuroscience Group, Steve Svec was promoted to associate publisher for the Neurol ogy Reviews and Neuropsychiatry Reviews publi cations. Chad Holloway has joined the company as account manager for Neurology Reviews, Neu roPsychiatry Reviews, and The International Jour nal of MS Care. Mr. Holloway previously was a media planner at Conectics Group. Brett Cogan has been named director of sales for Pulmonary Reviews and Respiratory Reviews. Mr. Cogan has joined Clinicians Group from Cunningham Associates where he served as national accounts manager. James J. MILLER HCPro Names Sales Director James J. Miller has been named director of sales, custom publishing for pharmaceutical, medical device, and biotechnology regulatory compliance at HCPro Inc., Marblehead, Mass. HCPro is a publisher and educator on regulatory and compliance issues faced by hospitals, home health organizations, nursing homes, physicians’ offices, and other healthcare facilities. In his current position, he specializes in merging the custom publishing, elearning, and customized healthcare compliance con tent from HCPro with the branding and OIG compliant marketing for toptier pharmaceu tical, medicaldevice, and biotech companies. Agency POOL Patrick BOSAK Cricket DARBY Dr. Gretchen P. EBERHART Michael GROFF Dr. Steve HENRY Erika MARCH Cynthia MEEHAN Kelley MEHAN Kevin MOFFITT Bernadette MORIARTY Sue SMITH Marlene SWENSON Catherine WEISS Ashley WOODS Craig YARWOOD Interlink Adds Staff Interlink Healthcare Communications, a full service healthcare advertis ing agency with integrated medicaleducation capa bilities, has undergone staffing changes. Interlink is part of the ICC Group of Companies, which is part of the Lowe Healthcare Worldwide network. Patrick Bosak has joined Interlink as art director. Before joining Interlink, he was an art director with Winning Strategies. Cricket Darby has been promoted to senior medical writer. Gretchen P. Eberhart, M.D., has been hired as medical director. She is a boardcertified endocrinologist. Before joining Interlink, she was on the faculty of the Uni versity of Pittsburgh School of Medicine. Michael Groff has been named copywriter. His most recent position was at Backe Communications. 66 A u gu s t 2 003 PharmaVOICE TALENT pool Steve Henry, M.D., M.S., has been named medical director in the company’s scientific affairs department. Before joining Interlink, he was a researcher in pharmacogenomics at GlaxoSmithKline. He also practiced internal medicine for 13 years. Erika March has been promoted to manag er, educational planning and development. Cynthia Meehan has been promoted to VP, group account supervisor. Kelley Mehan has been appointed manager, account coordination. Kevin Moffitt has joined the creative department as senior copywriter from a PR firm in British Columbia. Bernadette Moriarty has been promoted to VP, group account supervisor. Sue Smith has been promoted to VP, account supervisor. Before joining Interlink in 2000, she worked for six years in a variety of marketing capacities at BristolMyers Squibb. Marlene Swenson has been named project director at the agency. Ms. Swenson most recently was an education and meetings specialist at Aventis Pharmaceuticals. Catherine Weiss has been promoted to associ ate medical director. Ashley Woods has joined the agency as senior account executive. She is focusing on Interlink accounts in specialized areas such as oncology and transplantation. Craig Yarwood has joined Interlink as VP, group account supervisor. He previously worked for Lally McFarland Pantello as VP, account group supervisor. Jorge DEL MAZO Agency Veteran to head Euro RSCG Life NRP’s Marketing Practice and Global Business Euro RSCG Life NRP has appointed Jorge Del Mazo global business director of the marketing service group. Euro RSCG Life NRP, New York, develops and drives innovative and integrated communications solutions to help build its clients’ businesses. Euro RSCG Life is part of Euro RSCG Worldwide. He received his bachelor’s and his master’s in public affairs from the University of Colorado. Antoinette KENTON Carbon Healthcare Adds to Staff Carbon Healthcare Communications, Wayne, N.J., a CommonHealth professional advertising and promotion agency, has added Antoinette Kenton to its staff as an account supervisor. Ms. Kenton manages the strategic and tactical planning of her assigned brands throughout the products’ life cycles. She had been employed at Gilead Sciences as manager, global marketing. Bob KARCZEWSKI Richard J. LEVY Jeff LIPMAN Integrity Healthcare Names Key Executives Three of the top exec utives in pharmaceutical marketing — Rich Levy, Bob Karczewski, and Jeff Lipman — have joined forces at a new agency, Integrity Healthcare Communications, under the corporate umbrella of the HealthSTAR Communications network, Woodbridge, N.J. Mr. Levy, former CEO of AdairGreene Inc. and president of its healthcare division, was brought in to the HealthSTAR network to head the advertising group and serve as presi dent of Integrity. Mr. Karczewski, who has a 20year track record in the industry and is a registered pharmacist, is now executive VP and general manager of Integrity, which he, Mr. Levy and Mr. Lipman cofounded. Mr. Lip man is executive VP and creative director. Dr.William LIGHT Carla RESVANIS Palio Communications Announces Staff Appointments Palio Communications, Saratoga Springs, N.Y., an advertising and communications agen cy, has announced staff appointments. William Light, Ph.D., has joined Palio as medical informa tion specialist. He has more than 30 years of expe rience in life sciences. His work has beenpublished in several peerreviewed pro fessional journals, and he has authored five sci entific textbooks. Most recently, Dr. Light served as senior medical writer at MediTech Media. Dr. Light holds a Ph.D. in biology from the University of Arizona and bachelor’s and master’s degrees from San Francisco State University. Carla Resvanis has joined Palio as assistant editor. She has more than 20 years of editorial and communications experi ence. Ms. Resvanis holds a bachelor’s degree from New York University. Eileen LOVERN Reid SALEEBY The CementWorks Names Creative Director and Strategic Marketing Services VP The CementWorks, an independent, full service healthcare agency in New York, has named Eileen Lovern as creative director and senior VP. Ms. Lovern brings to the agency more than 13 years of consumer branding expe rience. Before joining The CementWorks, she was an associate creative director at Campbell Mithun Minneapolis of the InterPublic Group and at DMB&B in Sydney, Australia. In addition, Reid Saleeby has been named executive VP of strategic marketing services and is heading up the agency’s new office in Raleigh, N.C. Mr. Saleeby brings to The CementWorks 11 years of sales and marketing experience at GlaxoSmithKline on brands such as Advair, Serevent, Combivir, Ziagen, Zofran, Navelbine, Imitrex, and Zantac. He has a B.S. in pharmacy from the Uni versity of North Carolina at Chapel Hill and a MBA from Wake Forest University. Please send your personnel announcements to firstname.lastname@example.org. PardonUs … In the June issue of PharmaVOICE, Walt Rutherford, MBA,CPA,of PRA International Inc.,was listed as VP of operations. His correct title is director of business operations, PRA International. PharmaVOICEapolo gizes for the error.